共 79 条
[1]
Dulai PS(2019)Should we divide Crohn’s disease into ileum-dominant and isolated colonic diseases? Clin Gastroenterol Hepatol 17 2634-2643
[2]
Singh S(2018)Systematic review and network meta-analysis: first- and second-line biologic therapies for moderate-severe Crohn’s disease Aliment Pharmacol Ther 48 394-409
[3]
Fumery M(2017)Recent advances in clinical practice: a systematic review of isolated colonic Crohn’s disease: the third IBD? Gut 66 362-381
[4]
Sandborn WJ(2015)Extraintestinal manifestations of inflammatory bowel disease Inflamm Bowel Dis 21 1982-1992
[5]
Murad MH(2015)Inflammatory bowel disease: genetics, epigenetics, and pathogenesis Front Immunol 6 6-11
[6]
Subramanian S(2013)Nod1 and Nod2 signaling does not alter the composition of intestinal bacterial communities at homeostasis Gut Microbes 4 222-231
[7]
Ekbom A(2008)Molecular analysis of the gut microbiota of identical twins with Crohn’s disease ISME J 2 716-727
[8]
Rhodes JM(2020)Microbiome-based biomarkers for IBD Inflamm Bowel Dis 26 1463-1469
[9]
Vavricka SR(2019)Genetic factors and the intestinal microbiome guide development of microbe-based therapies for inflammatory bowel diseases Gastroenterology 156 2174-2189
[10]
Loddo I(2019)Correction: The 1000IBD project: multi-omics data of 1000 inflammatory bowel disease patients; data release 1 (BMC Gastroenterology (2019) 19:5 DOI: 10.1186/s12876-018-0917-5) BMC Gastroenterol 19 1-10